IQV Iqvia Holdings Earnings and EPS analysis

EPS in 2025 (TTM): $6.97

Last Report Period Date: Jun 30, 2025

According to the most recent financial data from June 2025, the EPS for the trailing twelve months is $6.97. Iqvia Holdings's EPS for 2024 amounted to $7.57, marking an increase from $7.39 in 2023. During the quarterly period ending on Jun 30, 2025, IQV's EPS stood at $1.55.

IQV earnings history

Historical annual and quarterly earnings per share (EPS) data for Iqvia Holdings
EPS (TTM)
$6.97
EPS Growth YoY (Quarterly)
-22.1%
EPS (Quarterly)
$1.55
EPS Growth (Quarterly)
9.2%

Iqvia Holdings had an annual EPS of $7.57, indicating an increase of 2.4% from $7.39 in 2023. The quarterly per-share earnings for the period ending Jun 30, 2025, was $1.55, indicating a 22.1% decrease from the same quarter last year. IQV's 12-month EPS stands at $6.97 as of June 2025. Iqvia Holdings's annual EPS in 2023 stood at $7.39, a 27% increase year-over-year.

IQV EPS growth

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
-22.1%
EPS growth YoY
2.4%
EPS growth 3Y avg
14.4%
EPS growth 5Y avg
50.5%

Iqvia Holdings has registered a decrease in EPS of 22.1% during the last 12 months (YoY, quarterly). In the last three years, IQV recorded an average annual EPS growth rate of 14.4%. Iqvia Holdings had an average annual EPS growth rate of 50.5% during the last 5 years. Across the last decade, IQV had an average annual EPS growth of 10.5%.

IQV Earnings Waterfall

Breakdown of revenue, profit and net income for Iqvia Holdings

IQV Earnings vs Peers

What are the earnings of IQV compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
IQV Iqvia Holdings Inc 28.58 2.4% 14.4% 50.5%
NWBO Northwest Biotherapeutics Inc N/A -16.7% N/A N/A

All data is based on quarterly TTM periods, unless otherwise specified.